RARE PHARMA-GRADE BARIUM SULFATE AND IODINE IN NORTH AMERICA
Voyageur Pharmaceuticals Ltd. (VM: TSX-V, OTC: VVYRF, Forum) is developing near term cash flow on its 100% owned high grade barium sulfate project in BC, Canada and, is actively exploring and developing Iodine brine projects in the USA.
VM business plan is to immediately develop its advanced stage pharmaceutical grade barium sulfate deposit, Frances Creek, and create cash flow. Voyageur is developing barium contrast radiographic suspension products for the pharmaceutical industry.
Frances Creek production start up scheduled for May 1st, 2021
VM’s pharmaceutical grade barite is naturally occurring with grades as high as 99.26% BaSO4 in-situ, which is very rare.
Voyageur has achieved a 98.6% BaSO4 product with SGS Minerals, which is the highest grade natural occurring barite in the world. The only barite sold in the market place, grading +98%, is man made in a lab using an expensive manufacturing processing.
The only other source of natural pharmaceutical grade barite is from China.
China only exports 5% of their production of pharmaceutical barite, allocating 95% for their domestic market.
The pharmaceutical industry is forced to use expensive man made barium sulfate for the radiographic market.